Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15Pemigatinib

02 6Ponatinib

03 4Ponatinib hydrochloride

04 3Ponatinibhydroklorid

05 3Put It Away

06 2Retifanlimab

07 1Retifanlimab

08 2Ruxolitinib

09 2Ruxolitinib Phosphate

10 4Tafasitamab

11 1Tafasitamabum

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

02

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 9mg

Packaging :

Brand Name : Pemazyre

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

03

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

04

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 135mg

Packaging :

Brand Name : Pemazyre

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

05

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 45mg

Packaging :

Brand Name : Pemazyre

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

Brand Name : Pemazyre

BioProcess International
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 9mg

Packaging :

Brand Name : Pemazyre

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 4.5MG

Packaging :

Brand Name : Pemazyre

Approval Date : 07-05-2021

Application Number : 1211535001

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 26-03-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

09

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength :

Packaging :

Brand Name : Pemazyre

Approval Date : 26-03-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

Brand Name : Pemazyre

BioProcess International US West
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
BioProcess International US West
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 26-03-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank